Updated Results from an Ongoing Phase 1 Clinical Study of bb21217 Anti-Bcma CAR T Cell Therapy International Myeloma Foundation 2:45 5 years ago 168 Далее Скачать
bb21217: next gen anti-BCMA CAR-T for R/R MM VJHemOnc – Video Journal of Hematology & HemOnc 2:28 4 years ago 91 Далее Скачать
Phase I CRB-402 Study of the BCMA-Targeted CAR T Cell Therapy bb21217 in Pts w/RR Multiple Myeloma International Myeloma Foundation 6:28 3 years ago 316 Далее Скачать
Phase I study of bb21217 CAR-T therapy in R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 4:47 3 years ago 98 Далее Скачать
Dr. Shah on Initial Results for bb21217 in Multiple Myeloma OncLive 0:42 6 years ago 213 Далее Скачать
Anti-BCMA CAR T-cells for MM: durable clinical responses with ide-cel (formerly bb2121) VJHemOnc – Video Journal of Hematology & HemOnc 3:17 6 years ago 172 Далее Скачать
ide-cel; bb2121, a BCMA-targeted CAR T-cell therapy, in patients with RRMM: Initial KarMMa results International Myeloma Foundation 10:18 4 years ago 1 621 Далее Скачать
Results from CAR T-cell bb2121 first-in-human trial for R/R MM VJHemOnc – Video Journal of Hematology & HemOnc 7:06 6 years ago 173 Далее Скачать
Brain tumor organoids accurately model patient response to CAR T cell therapy LetsTalkMedicine 0:45 1 day ago 449 Далее Скачать
Ide-cel (formerly bb2121) anti-BCMA CAR T-cell therapy in relapsed/refractory MM VJHemOnc – Video Journal of Hematology & HemOnc 1:56 7 years ago 270 Далее Скачать
From bb2121 to bb21217: does bb007 improve efficacy in MM? VJHemOnc – Video Journal of Hematology & HemOnc 2:40 4 years ago 339 Далее Скачать
Updated Results from CARTITUDE-1: Phase 1b/2Study of Cilta-Cel in Pts With RR Multiple Myeloma International Myeloma Foundation 4:25 3 years ago 479 Далее Скачать
bb21217 Shows Encouraging Efficacy, Safety, and CAR T-Cell Expansion DocWire 5:03 3 years ago 50 Далее Скачать
CAR-T therapy in multiple myeloma: recent updates, clinical trials and future outlooks VJHemOnc – Video Journal of Hematology & HemOnc 4:12 1 year ago 1 689 Далее Скачать
Phase 1 Study PHE885 BCMA-Directed CAR-T Cell Therapy for RRMM | Adam Sperling, MD, PhD | ASCO 2023 HealthTree Foundation for Multiple Myeloma 4:21 1 year ago 402 Далее Скачать
Update of CARTITUDE-1: A phase Ib/II study of JNJ-4528, a BCMA-directed CAR-T-cell therapy, in RRMM International Myeloma Foundation 3:54 4 years ago 417 Далее Скачать
Dr. Berdeja Discusses Study of bb2121 Anti-BCMA CAR-T Cell Therapy OncLive 1:44 6 years ago 213 Далее Скачать
Dr. Berdeja Discusses Results for bb2121 in Multiple Myeloma Targeted Oncology 3:55 7 years ago 392 Далее Скачать
Updated phase 1 results of teclistamab, a BCMA × CD3 bispecific antibody, in RRMM International Myeloma Foundation 7:25 3 years ago 419 Далее Скачать
Updated Results of the Idecabtagene Vicleucel (ide-cel bb2121) CRB-401 Trial in RR Multiple Myeloma International Myeloma Foundation 7:03 4 years ago 584 Далее Скачать
